When was Somite founded?

Somite was founded in 2023 and raised its 1st funding round 1 year after it was founded.

Where is Somite located?

Somite is headquartered in Boston, United States.

Who is the current CEO of Somite?

Micha Y Breakstone of Somite. They have also founded 1 company.

How many employees does Somite have?

As of Sep 30, 2026, the latest employee count at Somite is 95.

Is Somite a funded company?

Somite is a funded company, having raised a total of $60M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 16, 2024.

When was the latest funding round of Somite?

Somite's latest funding was a $***** Series A round on May 13, 2025, with participation from 8 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $4B in funding in 2026 to date.

Where does Somite rank among its competitors?

Somite ranks 73rd amongst 2604 active competitors, of which 888 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Somite?

Somite's top competitors include Jazz Pharmaceuticals, Tango Therapeutics and Elicio. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Somite - 2026 Company Profile, Team, Funding & Competitors

Somite is a series A company based in Boston (United States), founded in 2023 by Micha Y Breakstone, Jay Shendure, Olivier Pourquie, Cliff Tabin and Allon Klein. It operates as an AI-driven platform to produce human tissue for cell-based therapies. Somite has raised $60M in funding from investors like Khosla Ventures, Astellas Venture Management and Montage Ventures. The company has 2604 active competitors, including 888 funded and 621 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Tango Therapeutics and Elicio.

Company Details

AI-driven platform to produce human tissue for cell-based therapies. The company develops a digital twin of the embryo, a computational model simulating real embryo development to guide decision-making for generating cell-based therapies.

Website: somite.ai
Social
Email ID: *****@somite.ai

Key Metrics

Founded Year

2023

Location

Boston, United States

Stage

Series A

Total Funding

$60M in 3 rounds

Latest Funding Round

Series A, May 13, 2025, $*****

Investors

Khosla Ventures & 14 more

Ranked

73^rd among 2604 active competitors

Employee Count

95 as on Sep 30, 2026

Similar Companies

Cytel & 164 more

View Somite's full profile

Somite has raised a total funding of $60M over 3 rounds. Its first funding round was on Apr 16, 2024. Its latest funding round was a Series A round on May 13, 2025 for $*****. 8 investors participated in its latest round. Somite has 12 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Somite:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 13, 2025	2404459	Series A	9379859	1905057	5187019	8212570
Sep 03, 2024	8313248	Seed	5369329	7230177	1421372	4330523
Apr 16, 2024	1088304	Seed	4443973	7002614	7680607	TechAviv & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Somite's funding rounds and investors

The founders of Somite are Micha Y Breakstone, Jay Shendure, Olivier Pourquie, Cliff Tabin and Allon Klein. Micha Y Breakstone is the CEO of Somite.

Here are the details of Somite's key team members:

Micha Y Breakstone: Co-Founder & CEO of Somite and founder of 2 other companies, Neuralight and Chorus.ai.
Contact Info: 1 email address
Jay Shendure: Co-Founder of Somite.
Contact Info: 1 email address
Olivier Pourquie: Co-Founder of Somite.
Contact Info: 1 email address
Cliff Tabin: Co-Founder of Somite.
Contact Info: 1 email address
Allon Klein: Co-Founder of Somite.
Contact Info: 1 email address

View details of Somite's Founder profiles and Board Members

Somite's employee count trend

Somite has 95 employees as of Sep 26. Here is Somite's employee count trend over the years:

Uncover Somite's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Somite include Jazz Pharmaceuticals, Tango Therapeutics and Elicio. Here is the list of Top 10 competitors of Somite, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Tango Therapeutics 2017, Cambridge (United States), Public	Developer of drugs for the treatment of cancer	$165M	Boxer Capital, Casdin Capital & 8 others	72/100
3rd	Elicio 2012, Cambridge (United States), Public	Developer of vaccines for treating cancer	$47.4M	Dreavent, Efung Capital & 5 others	72/100
4th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 22 others	71/100
5th	BioNTech 2008, Mainz (Germany), Public	Developer of immunotherapeutics for the treatment of cancer and other diseases	$861M	Fidelity Investments, Redmile Group & 28 others	71/100
6th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	71/100
7th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	70/100
8th	Deciphera 2003, Waltham (United States), Acquired	Developer of type 2 kinase inhibitors for treating cancer	$173M	Redmile Group, New Leaf Venture Partners & 4 others	70/100
9th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	69/100
10th	Relay Therapeutics 2016, Cambridge (United States), Public	Developer of drug discovery platform and study protein motion	$520M	BVF Partners, SoftBank Vision Fund & 17 others	69/100
73rd	Somite 2023, Boston (United States), Series A	AI-driven platform to produce human tissue for cell-based therapies	$60M	SciFi, Harpoon & 13 others	63/100